MilliporeSigma’s CHOZN® Expression System Selected for Bi-specific Antibody Development by SystImmune

 Accelerates development timelines with faster, easier selection and scale up of clones  Delivers higher titers of recombinant proteins Billerica, Massachusetts, May 16, 2017 — MilliporeSigma today announced that its CHOZN® expression system will be used by SystImmune, a Seattle-based biotechnology company, for commercial development of a bi-specific antibody therapeutic. The CHOZN® expression system is designed... Read more

Thermo Fisher Scientific Strengthens Portfolio of Endotoxin-Free Plasmid DNA Isolation Kits

Thermo Fisher Scientific Inc. , the world leader in serving science, has expanded its line of endotoxin-free plasmid DNA isolation products with the launch of the PureLink Expi Endotoxin-Free Maxi Plasmid Purification Kit. With a simple and fast protocol for isolation, the kit allows researchers to yield up to 1.5 mg of endotoxin-free, advanced transfection-quality... Read more

Agilent Technologies Announces Expanded Use for PD-L1 IHC 28-8 pharmDx Diagnostic in Europe

Approved for Use in Europe to Identify Head and Neck Cancer Patients Most Likely to Benefit from Opdivo (nivolumab) Therapy SANTA CLARA, Calif., May 15, 2017 Agilent Technologies Inc. (NYSE: A) today announced the expanded use of Agilent’s Dako PD-L1 IHC 28-8 pharmDx test for squamous cell carcinoma of the head and neck (SCCHN), the... Read more

Thermo Fisher Scientific to Acquire Patheon, a Leading Contract Development and Manufacturing Organization (CDMO)

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and Patheon N.V. (NYSE: PTHN), a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, today announced that their boards of directors have approved Thermo Fisher’s acquisition of Patheon. Thermo Fisher will commence a tender offer... Read more

MilliporeSigma Opens New M Lab™ Collaboration Center in Bangalore

May 12, 2017 MilliporeSigma Opens New M Lab™ Collaboration Center in Bangalore Customers can explore new technologies and solutions to address development and manufacturing challenges Simulates a GMP manufacturing environment to accelerate development of new therapies MilliporeSigma, a leading science and technology company, today announced the expansion of its M Lab™ Collaboration Center in Bangalore,... Read more